These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 34186160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.
    Balasubramani A, Larjo A, Bassein JA, Chang X, Hastie RB, Togher SM, Lähdesmäki H, Rao A.
    Nat Commun; 2015 Jun 22; 6():7307. PubMed ID: 26095772
    [Abstract] [Full Text] [Related]

  • 5. [Molecular mechanisms by which the mutant ASXL1/BAP1 complex aggravates myeloid leukemia].
    Asada S.
    Rinsho Ketsueki; 2020 Jun 22; 61(4):392-405. PubMed ID: 32378586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Loss of BAP1 function leads to EZH2-dependent transformation.
    LaFave LM, Béguelin W, Koche R, Teater M, Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T, Konstantinoff K, Micol JB, Durham B, Knutson SK, Campbell JE, Blum G, Shi X, Doud EH, Krivtsov AV, Chung YR, Khodos I, de Stanchina E, Ouerfelli O, Adusumilli PS, Thomas PM, Kelleher NL, Luo M, Keilhack H, Abdel-Wahab O, Melnick A, Armstrong SA, Levine RL.
    Nat Med; 2015 Nov 22; 21(11):1344-9. PubMed ID: 26437366
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
    Lee SW, Youn H, Kim EJ, Um SJ.
    Mol Cell; 2013 Jul 25; 51(2):200-10. PubMed ID: 23850490
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119.
    Köhnke T, Nuno KA, Alder CC, Gars EJ, Phan P, Fan AC, Majeti R.
    Blood Cancer Discov; 2024 May 01; 5(3):202-223. PubMed ID: 38359087
    [Abstract] [Full Text] [Related]

  • 15. HHEX promotes myeloid transformation in cooperation with mutant ASXL1.
    Takeda R, Asada S, Park SJ, Yokoyama A, Becker HJ, Kanai A, Visconte V, Hershberger C, Hayashi Y, Yonezawa T, Tamura M, Fukushima T, Tanaka Y, Fukuyama T, Matsumoto A, Yamasaki S, Nakai K, Yamazaki S, Inaba T, Shibata T, Inoue D, Honda H, Goyama S, Maciejewski JP, Kitamura T.
    Blood; 2020 Oct 01; 136(14):1670-1684. PubMed ID: 32492700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
    Abdel-Wahab O, Dey A.
    Leukemia; 2013 Jan 01; 27(1):10-5. PubMed ID: 23147254
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Generation and Characterization of Induced Pluripotent Stem Cells Carrying An ASXL1 Mutation.
    Wang W, Zhang X, Li Y, Shen J, Li Y, Xing W, Bai J, Shi J, Zhou Y.
    Stem Cell Rev Rep; 2024 Oct 01; 20(7):1889-1901. PubMed ID: 38884929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.